29.07.2024 15:39:19

EQS-AFR: Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Epigenomics AG / Preliminary announcement on the disclosure of financial statements
Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

29.07.2024 / 15:39 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Epigenomics AG hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report (half-year/Q2)

Language: German
Date of disclosure: July 30, 2024
Address: https://www.epigenomics.com/de/news-investoren/finanzberichte/


29.07.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Epigenomics AG
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany
Internet: www.epigenomics.com

 
End of News EQS News Service

1956223  29.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1956223&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu Epigenomics AG Nach Kapitalherabsetzungmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Epigenomics AG Nach Kapitalherabsetzung 1,43 2,14% Epigenomics AG Nach Kapitalherabsetzung